Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $37,700 | 9 | 83.0% |
| Travel and Lodging | $4,870 | 12 | 10.7% |
| Food and Beverage | $1,192 | 11 | 2.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,125 | 1 | 2.5% |
| Honoraria | $500.00 | 1 | 1.1% |
| Education | $14.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $37,578 | 13 | $0 (2017) |
| Halozyme Inc | $3,936 | 10 | $0 (2018) |
| Aurobindo Pharma USA, Inc. | $1,500 | 1 | $0 (2019) |
| Covidien LP | $1,221 | 3 | $0 (2018) |
| INTRA-SANA LABORATORIES | $500.00 | 1 | $0 (2021) |
| SANOFI US SERVICES INC. | $468.19 | 4 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $100.77 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $84.28 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $14.50 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $100.77 | 1 | AstraZeneca Pharmaceuticals LP ($100.77) |
| 2022 | $84.28 | 1 | Gilead Sciences, Inc. ($84.28) |
| 2021 | $500.00 | 1 | INTRA-SANA LABORATORIES ($500.00) |
| 2019 | $1,500 | 1 | Aurobindo Pharma USA, Inc. ($1,500) |
| 2018 | $5,125 | 13 | Halozyme Inc ($3,936) |
| 2017 | $38,091 | 18 | Novo Nordisk Inc ($37,578) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $100.77 | General |
| Category: Oncology | ||||||
| 05/11/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $84.28 | General |
| Category: HCV | ||||||
| 11/30/2021 | INTRA-SANA LABORATORIES | RELTONE 200 MG (Drug), RELTONE 400 MG | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: Gallstones | ||||||
| 08/17/2019 | Aurobindo Pharma USA, Inc. | Khapzory (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Oncology | ||||||
| 08/07/2018 | Halozyme Inc | — | Travel and Lodging | Cash or cash equivalent | $170.07 | General |
| 07/11/2018 | Halozyme Inc | Hylenex (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Opthalmology | ||||||
| 07/11/2018 | Halozyme Inc | Hylenex (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Opthalmology | ||||||
| 07/10/2018 | Halozyme Inc | Hylenex (Drug) | Travel and Lodging | In-kind items and services | $239.00 | General |
| Category: Opthalmology | ||||||
| 07/10/2018 | Halozyme Inc | Hylenex (Drug) | Travel and Lodging | In-kind items and services | $25.10 | General |
| Category: Opthalmology | ||||||
| 07/10/2018 | Halozyme Inc | Hylenex (Drug) | Travel and Lodging | In-kind items and services | $4.78 | General |
| Category: Opthalmology | ||||||
| 07/10/2018 | Halozyme Inc | Hylenex (Drug) | Travel and Lodging | In-kind items and services | $0.47 | General |
| Category: Opthalmology | ||||||
| 07/09/2018 | Halozyme Inc | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 07/06/2018 | Halozyme Inc | Hylenex (Drug) | Travel and Lodging | In-kind items and services | $89.70 | General |
| Category: Opthalmology | ||||||
| 06/21/2018 | Halozyme Inc | Hylenex (Drug) | Travel and Lodging | In-kind items and services | $1,357.00 | General |
| Category: Opthalmology | ||||||
| 05/30/2018 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Education | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 04/14/2018 | Covidien LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| 04/14/2018 | Covidien LP | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 07/31/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $280.79 | General |
| 07/31/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $165.00 | General |
| 07/31/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| 07/31/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | Cash or cash equivalent | $5.55 | General |
| 06/28/2017 | Covidien LP | Barrx (Device) | Food and Beverage | In-kind items and services | $45.76 | General |
| Category: GIH | ||||||
| 06/18/2017 | Novo Nordisk Inc | Victoza (Drug) | Consulting Fee | Cash or cash equivalent | $10,800.00 | General |
| Category: Diabetes | ||||||
| 06/18/2017 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $1,327.00 | General |
| Category: Diabetes | ||||||
| 06/18/2017 | Novo Nordisk Inc | Victoza (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 16 | 16 | $13,280 | $3,044 |
| 2020 | 1 | 12 | 12 | $9,960 | $2,287 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $13,280 | $3,044 | 22.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $9,960 | $2,287 | 23.0% |
About Dr. Anil Rustgi, MD
Dr. Anil Rustgi, MD is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609919588.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil Rustgi, MD has received a total of $45,402 in payments from pharmaceutical and medical device companies, with $100.77 received in 2023. These payments were reported across 35 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($37,700).
As a Medicare-enrolled provider, Rustgi has provided services to 28 Medicare beneficiaries, totaling 28 services with total Medicare billing of $5,331. Data is available for 2 years (2020–2021), covering 2 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Gastroenterology
- Location New York, NY
- Active Since 02/14/2007
- Last Updated 11/19/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609919588
Products in Payments
- Victoza (Drug) $37,578
- Hylenex (Drug) $1,765
- Khapzory (Drug) $1,500
- RELTONE 200 MG (Drug) $500.00
- NO PRODUCT DISCUSSED (Drug) $468.19
- CALQUENCE (Drug) $100.77
- Epclusa (Drug) $84.28
- Barrx (Device) $45.76
- Kanuma (Drug) $14.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M